ACADIA PHARMACEUTICALS INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6b3343b0-c07d-47db-83fd-9e571f6044ed/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $104.8M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-072519 |
| FY 2024 | $230.8M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029253 |
| FY 2023 | $-73.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-021473 |
| FY 2022 | $-223.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-004757 |
| FY 2021 | $-170.4M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002392 |
| FY 2020 | $-286.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008372 |
| FY 2019 | $-246.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006889 |
| FY 2018 | $-247.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004596 |
| FY 2017 | $-292.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003526 |
| FY 2016 | $-272.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002866 |
| FY 2015 | $-164.6M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-483533 |
| FY 2014 | $-93.2M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-066078 |
| FY 2013 | $-38.3M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-073040 |
| FY 2012 | $-20.9M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-103111 |
| FY 2011 | $-22.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-098990 |
| FY 2010 | $15.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-098990 |
| FY 2009 | $-45.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-098990 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACADIA PHARMACEUTICALS INC. — all facts · Revenue · Net Income